A clinical trial of Kali muriaticum in cases of Allergic Rhinitis through eosinophilic count

A prospective clinical study of Kalium Muriaticum in Allergic Rhinitis by assessing absolute eosinophilic count

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/01/049290

Enrollment

Registered

2023-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

Intervention1: Kalium Muriaticum: Potentised homoeopathic medicine in the form of pills or powder dose:Dose: 1dram or 1/2 dram will be prescribed : Frequency: twice a day will be prescribed: Route of

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient who fulfill the case definition. 2) Patients of both sexes above 18 years of age group will be included

Exclusion criteria

Exclusion criteria: 1) Cases presenting with any gross pathology such as, bronchial asthma, recurrent sinusitis, otitis media. 2) Pregnant and Lactating female. 3) Patient in emergency conditions are excluded

Design outcomes

Primary

Measure	Time frame
To achieve improvement by accessing the Absolute Eosinophilic Count levels upon giving kalium Muriaticum in cases of Allergic RhinitisTimepoint: Improvement by assessing the Absolute Eosinophilic Count levels with follow up taken after 5-7 days of medicine prescribed continued for 5 follow ups with Absolute Eosinophilic Count recorded at the starting and end of study. Study Duration will be of 10-12 weeks.	—

Measure

Time frame

To achieve improvement by accessing the Absolute Eosinophilic Count levels upon giving kalium Muriaticum in cases of Allergic RhinitisTimepoint: Improvement by assessing the Absolute Eosinophilic Count levels with follow up taken after 5-7 days of medicine prescribed continued for 5 follow ups with Absolute Eosinophilic Count recorded at the starting and end of study. Study Duration will be of 10-12 weeks.

—

Secondary

Measure	Time frame
To check the Effectiveness of Kalium Muriaticum in the cases of Allergic RhinitisTimepoint: The follow ups taken within 5-7 days continues for 5 follow up within the study Duration of 10-12 weeks will be used to assess the effect of homeopathic medicine Kalium Muriaticum in the patients suffering from Allergic Rhinitis.	—

Countries

India

Contacts

Public ContactDr Pragya Srivastava

B V.D.U. Homoeopathic Medical College and Hospital ,Dept of Post graduate and Research centre

Sheetal.Patil@bharatividyapeeth.edu9850545835

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026